PrescriptionDrugs.org

What to Expect When Starting Meloxicam

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that preferentially inhibits cyclooxygenase-2 (COX-2) over COX-1, giving it a somewhat better gastrointestinal safety profile compared to non-selective NSAIDs like ibuprofen or naproxen [1]. It is primarily prescribed for osteoarthritis and rheumatoid arthritis, and is one of the few prescription NSAIDs with convenient once-daily dosing [2]. Available in 7.5 mg and 15 mg tablets, meloxicam provides sustained anti-inflammatory and analgesic effects throughout the day.

Meloxicam works by reducing prostaglandin synthesis through COX-2 inhibition, which decreases inflammation, pain, and stiffness in affected joints [1]. Its preferential COX-2 selectivity means it causes somewhat less gastric mucosal damage than traditional NSAIDs, though GI risks are not eliminated and the cardiovascular risk profile is similar to other NSAIDs [2][3].

This guide covers what to expect when starting meloxicam, including the timeline for achieving full anti-inflammatory effects, common side effects, and important safety information. As with all NSAIDs, the FDA recommends using the lowest effective dose for the shortest duration consistent with treatment goals [3]. Always follow your prescriber's specific instructions.

Week-by-week timeline

First doseMeloxicam reaches steady-state levels after about 3-5 days of consistent dosing. Do not increase your dose to get faster relief [1].

Initial effects

Meloxicam is absorbed after oral administration with peak plasma concentrations reached in approximately 5-6 hours [1]. Some pain relief may be noticeable within the first day, but the full anti-inflammatory effect takes longer to develop. Unlike ibuprofen, which has a rapid onset, meloxicam has a longer half-life (about 20 hours) that supports once-daily dosing but means it takes several days to reach steady-state levels [2].

  • Mild pain relief may begin within hours
  • Full effects not yet apparent — this is expected
  • Take with or without food (food slightly delays but does not reduce absorption)
  • Typically well-tolerated on the first day
Days 2-5Take meloxicam at the same time each day for consistent blood levels. If GI discomfort occurs, taking it with food or milk may help [1].

Building to steady state

Meloxicam accumulates to steady-state blood levels over 3 to 5 days of daily dosing [1]. During this period, the anti-inflammatory effect progressively builds. Patients often notice increasing relief from joint stiffness, swelling, and pain each day. GI side effects, if they occur, typically appear during this establishment phase — dyspepsia affects approximately 4-8% of patients, and abdominal pain occurs in about 2-4% [2].

  • Progressive improvement in joint pain and stiffness
  • Possible mild dyspepsia or stomach discomfort
  • Once-daily dosing becoming routine
  • Gradual reduction in morning stiffness for arthritis patients
Weeks 1-2If you have not experienced meaningful improvement after 2 weeks at the maximum dose, discuss alternatives with your provider [2].

Full therapeutic effect

By 1 to 2 weeks, meloxicam has reached its full anti-inflammatory potential at the prescribed dose [2]. For osteoarthritis patients, this typically means meaningful improvement in joint function, reduced morning stiffness, and better mobility. Your provider may start you at 7.5 mg daily and increase to 15 mg if needed, based on your response [1]. The majority of therapeutic benefit is evident within the first 2 weeks.

  • Full anti-inflammatory benefit established
  • Significant improvement in joint pain and function
  • GI side effects stabilized or absent
  • Better ability to perform daily activities
  • Provider may assess response and adjust dose
Month 1+Report any new GI symptoms, blood pressure changes, or swelling promptly. Long-term NSAID use requires regular medical follow-up [3].

Long-term management

For chronic conditions like osteoarthritis, meloxicam is often used long-term. As with all NSAIDs, cardiovascular risk increases with duration of use [3]. Your provider will periodically monitor blood pressure, kidney function, and watch for GI complications. The annual risk of serious GI events is lower with meloxicam than with non-selective NSAIDs but is not zero — the MELISSA trial showed meloxicam had significantly fewer GI adverse events than diclofenac [4]. Periodic reassessment of the need for continued NSAID therapy is standard practice.

  • Stable symptom management with daily dosing
  • Provider monitoring at regular intervals
  • Ongoing cardiovascular and GI risk management
  • Periodic reassessment of the lowest effective dose
  • Integration with physical therapy and lifestyle measures

When to call your doctor

Contact your healthcare provider if you experience:

  • Black, tarry, or bloody stools, or vomiting blood — signs of GI bleeding [1][3]
  • Severe stomach pain or persistent heartburn not relieved by antacids [1]
  • Chest pain, shortness of breath, weakness on one side of the body, or slurred speech — cardiovascular events carry a boxed warning for all NSAIDs [3]
  • Swelling of face, lips, tongue, or throat, or difficulty breathing — allergic reaction [1]
  • Decreased urination, ankle swelling, or unexplained weight gain — possible kidney effects [1]
  • Skin rash, blistering, or peeling — rare serious skin reactions [1]
  • Yellowing of skin or eyes, dark urine — signs of liver injury [1]
  • New or worsening high blood pressure [3]

Tips for getting started

Take meloxicam once daily at the same time each day, with or without food [1]. Taking it with a meal may reduce mild stomach discomfort. Swallow tablets whole with a full glass of water and remain upright for at least 15-30 minutes after taking the dose. Consistency in timing helps maintain steady blood levels and maximizes the anti-inflammatory benefit.

Do not combine meloxicam with other NSAIDs (ibuprofen, naproxen, aspirin for pain), as this increases GI and cardiovascular risk without additional therapeutic benefit [3]. If you take low-dose aspirin for heart protection, be aware of potential interactions — discuss timing with your provider. Limit alcohol consumption, as it increases GI bleeding risk when combined with NSAIDs.

Stay hydrated and monitor your blood pressure regularly if you have hypertension [1]. NSAIDs can raise blood pressure and reduce the effectiveness of some antihypertensive medications. For arthritis management, combine meloxicam with regular low-impact exercise, physical therapy, and weight management for optimal results — medication alone is less effective than a comprehensive approach. Store at room temperature away from moisture and light.

Frequently asked questions

More about Meloxicam

References

  1. [Regulatory] Meloxicam FDA Prescribing Information. Boehringer Ingelheim. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020938s033lbl.pdf Accessed 2026-03-01.
  2. [Regulatory] Meloxicam. StatPearls [Internet]. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK554499/ Accessed 2026-03-01.
  3. [Regulatory] FDA Drug Safety Communication: FDA strengthens warning that NSAIDs increase heart attack and stroke risk. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-strengthens-warning-non-steroidal-anti-inflammatory-drugs-nsaids Accessed 2026-03-01.
  4. [Clinical] Hawkey C, et al. Comparison of the effect of meloxicam vs diclofenac on upper gastrointestinal safety (MELISSA study). Br J Rheumatol. 1998;37(9):937-945. https://pubmed.ncbi.nlm.nih.gov/9783757/ Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: